P, T., H, S., R, H., J, M., EM, S., & S, C. (2026). Pharmacotherapy and overdose risk following new opioid use disorder diagnosis among Medicaid beneficiaries. The American journal of drug and alcohol abuse, 52(1), 64. https://doi.org/10.1080/00952990.2025.2557917
Chicago Style (17th ed.) CitationP, Treitler, Samples H, Hermida R, Miles J, Stone EM, and Crystal S. "Pharmacotherapy and Overdose Risk Following New Opioid Use Disorder Diagnosis Among Medicaid Beneficiaries." The American Journal of Drug and Alcohol Abuse 52, no. 1 (2026): 64. https://doi.org/10.1080/00952990.2025.2557917.
MLA (9th ed.) CitationP, Treitler, et al. "Pharmacotherapy and Overdose Risk Following New Opioid Use Disorder Diagnosis Among Medicaid Beneficiaries." The American Journal of Drug and Alcohol Abuse, vol. 52, no. 1, 2026, p. 64, https://doi.org/10.1080/00952990.2025.2557917.